CareDirections, Carium commercialises stroke care platform – GWC Mag

CareDirections, in partnership with Carium, has announced the commercial availability of a digital health platform, named StrokeCP, which is designed to enhance post-stroke care management.  

This platform has been designed by Atrium Health Wake Forest Baptist researchers and powered by Carium’s patient engagement and virtual care management solution. 

It is based on insights gathered from the COMPASS study, which spanned five years and involved 40 hospital sites in North Carolina. 

StrokeCP integrates various tools and interventions to support stroke survivors after discharge, aiming to improve outcomes and reduce healthcare costs.  

The solution offers bidirectional integration with electronic medical record systems and allows providers to capture social and functional determinants of health at the point of care.  

Additionally, the platform merges clinical and demographic data with medication information, using proprietary algorithms to identify stroke-specific recovery barriers for each patient. 

Patients using StrokeCP receive personalised care plans with a tailored list of resources to aid their recovery.  

The platform also features remote monitoring, coaching, and facilitates communication between patients and providers, while tracking and communicating patient outcomes and satisfaction. 

According to Carium, the upcoming Centers for Medicare & Medicaid Services requirement, starting January 2024, mandates hospitals to screen for five specific social determinants of health risk factors.  

The American Heart Association has highlighted the link between these factors and increased stroke risk, with studies indicating racial and ethnic disparities in stroke incidence and recovery outcomes. 

In response, Carium and CareDirections are also developing other condition-specific care pathways to provide personalised care for various health issues such as post-acute cardiac recovery, dementia, bariatric surgery and weight management. 

Carium chief operating officer David McCormick said: “Wake Forest clinical researchers demonstrated that StrokeCP optimised care across the entire post-acute journey, improving not only clinical outcomes but financial results as well – through reductions in length of stay and readmissions, operational efficiencies, in-network follow-up care, and enhanced quality metric reporting for value-based care incentives.  

“This shows the solution can ensure both clinical excellence and financial return, which is crucial for the health systems.”